COVID-19 and Diabetes

Diabetes mellitus (DM) is one of the most common comorbid conditions in persons with COVID-19 and a risk factor for poor prognosis. The reasons why COVID-19 is more severe in persons with DM are currently unknown although the scarce data available on patients with DM hospitalized because of COVID-19...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Virginia Bellido, Antonio Pérez
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	diabetes mellitus COVID-19 hyperglycemia glycemic control blood glucose monitoring telemedicine Medicine R
Acceso en línea:	https://doaj.org/article/cc68ca341ed64925b8010453c97713e5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cc68ca341ed64925b8010453c97713e5
record_format	dspace
spelling	oai:doaj.org-article:cc68ca341ed64925b8010453c97713e52021-11-25T18:01:54ZCOVID-19 and Diabetes10.3390/jcm102253412077-0383https://doaj.org/article/cc68ca341ed64925b8010453c97713e52021-11-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/22/5341https://doaj.org/toc/2077-0383Diabetes mellitus (DM) is one of the most common comorbid conditions in persons with COVID-19 and a risk factor for poor prognosis. The reasons why COVID-19 is more severe in persons with DM are currently unknown although the scarce data available on patients with DM hospitalized because of COVID-19 show that glycemic control is inadequate. The fact that patients with COVID-19 are usually cared for by health professionals with limited experience in the management of diabetes and the need to prevent exposure to the virus may also be obstacles to glycemic control in patients with COVID-19. Effective clinical care should consider various aspects, including screening for the disease in at-risk persons, education, and monitoring of control and complications. We examine the effect of COVID-19 on DM in terms of glycemic control and the restrictions arising from the pandemic and assess management of diabetes and drug therapy in various scenarios, taking into account factors such as physical exercise, diet, blood glucose monitoring, and pharmacological treatment. Specific attention is given to patients who have been admitted to hospital and critically ill patients. Finally, we consider the role of telemedicine in the management of DM patients with COVID-19 during the pandemic and in the future.Virginia BellidoAntonio PérezMDPI AGarticlediabetes mellitusCOVID-19hyperglycemiaglycemic controlblood glucose monitoringtelemedicineMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5341, p 5341 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	diabetes mellitus COVID-19 hyperglycemia glycemic control blood glucose monitoring telemedicine Medicine R
spellingShingle	diabetes mellitus COVID-19 hyperglycemia glycemic control blood glucose monitoring telemedicine Medicine R Virginia Bellido Antonio Pérez COVID-19 and Diabetes
description	Diabetes mellitus (DM) is one of the most common comorbid conditions in persons with COVID-19 and a risk factor for poor prognosis. The reasons why COVID-19 is more severe in persons with DM are currently unknown although the scarce data available on patients with DM hospitalized because of COVID-19 show that glycemic control is inadequate. The fact that patients with COVID-19 are usually cared for by health professionals with limited experience in the management of diabetes and the need to prevent exposure to the virus may also be obstacles to glycemic control in patients with COVID-19. Effective clinical care should consider various aspects, including screening for the disease in at-risk persons, education, and monitoring of control and complications. We examine the effect of COVID-19 on DM in terms of glycemic control and the restrictions arising from the pandemic and assess management of diabetes and drug therapy in various scenarios, taking into account factors such as physical exercise, diet, blood glucose monitoring, and pharmacological treatment. Specific attention is given to patients who have been admitted to hospital and critically ill patients. Finally, we consider the role of telemedicine in the management of DM patients with COVID-19 during the pandemic and in the future.
format	article
author	Virginia Bellido Antonio Pérez
author_facet	Virginia Bellido Antonio Pérez
author_sort	Virginia Bellido
title	COVID-19 and Diabetes
title_short	COVID-19 and Diabetes
title_full	COVID-19 and Diabetes
title_fullStr	COVID-19 and Diabetes
title_full_unstemmed	COVID-19 and Diabetes
title_sort	covid-19 and diabetes
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/cc68ca341ed64925b8010453c97713e5
work_keys_str_mv	AT virginiabellido covid19anddiabetes AT antonioperez covid19anddiabetes
_version_	1718411707969175552

COVID-19 and Diabetes

Ejemplares similares